NCT05027425 2026-05-06Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantUniversity of CincinnatiPhase 2 Terminated8 enrolled 9 charts
NCT03534141 2025-05-16MHALTUniversity of California, San FranciscoPhase NA Terminated175 enrolled 19 charts